Eight15,
Since I have the answer at at hand,
Regarding BCG and Low Grade Tumours, the following article is a good starting point.
'Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer'
From, Nature Reviews Urology volume12, pages 225–235(2015)
Beginning on (about page 6) under the section header,
"Review of current guidelines on BCG use"
See the BCG recommendations for various initial presentations.
From the text, "Consensus exists for small, solitary, superficial low-grade tumours (Ta) with all groups agreeing that BCG is not indicated in this setting given the very low risk of disease progression."
The entire article discusses specific aspects of BCG decision making, and the contributor list includes well credentialed major researchers and clinicians.
Extensive footnotes provide further information and resources.
Full Article at:
www.nature.com/nrurol/journal/v12/n4/full/nrurol.2015.58.html
ALWAYS verify ANY recommendation or information from a publication or the internet with YOUR care team who knows YOUR situation. One size does not fit all.
Best,
Jack